Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women
- PMID: 2292078
- DOI: 10.1007/BF02555883
Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women
Abstract
We studied 20 healthy premenopausal women aged 36.5 +/- 4.0 years (mean +/- 1 SD), 123 healthy postmenopausal women aged 50.0 +/- 2.4 years, and 103 postmenopausal women aged 65.1 +/- 5.6 years with symptomatic osteoporosis (forearm and spinal fracture). Serum levels of vitamin D metabolites [25(OH)D, 24,25(OH)2D3, and 1,25-(OH)2D] were compared with (1) bone mass in the forearm (single photon absorptiometry) and in the spine (dual photon absorptiometry); (2) biochemical indices of bone formation (serum alkaline phosphatase, plasma bone Gla protein), and bone resorption (fasting urinary hydroxyproline); and (3) other biochemical estimates of calcium metabolism (serum calcium, serum phosphate, 24-hour urinary calcium, intestinal absorption of calcium). The present study revealed no difference in any of the vitamin D metabolites between the premenopausal women, the healthy postmenopausal women and the osteoporotic women as a group. The concentrations of 1,25(OH)2D and 25(OH)D were significantly lower in patients with spinal fracture than in those with forearm fracture. In the early postmenopausal women serum 1,25(OH)D was related to forearm bone mass (r = -0.20; P less than 0.05), intestinal calcium absorption (r = 0.18; P less than 0.05), and 24-hour urinary calcium (r = 0.21; P less than 0.05); serum 25(OH)D was related to spinal bone mass (r = 0.23; P less than 0.01). In the osteoporotic women, serum vitamin D metabolites were not related to bone mass, but 1,25(OH)2D was related to bone Gla protein (r = 0.33; P less than 0.001), serum phosphate (r = -0.27; P less than 0.01), and 24-hour urinary calcium (r = 0.43; P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Is heritability a risk factor for postmenopausal osteoporosis?J Bone Miner Res. 1992 Sep;7(9):1037-43. doi: 10.1002/jbmr.5650070906. J Bone Miner Res. 1992. PMID: 1414496
-
Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.Bone Miner. 1990 May;9(2):137-52. doi: 10.1016/0169-6009(90)90080-y. Bone Miner. 1990. PMID: 2161692 Clinical Trial.
-
Influence of age on effects of endogenous 1,25-dihydroxyvitamin D on calcium absorption in normal women.Calcif Tissue Int. 1994 Nov;55(5):330-4. doi: 10.1007/BF00299309. Calcif Tissue Int. 1994. PMID: 7866911 Clinical Trial.
-
Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.Rheum Dis Clin North Am. 1994 Aug;20(3):759-75. Rheum Dis Clin North Am. 1994. PMID: 7984788 Review.
-
Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis.J Nutr Sci Vitaminol (Tokyo). 1985 Dec;31 Suppl:S61-5. doi: 10.3177/jnsv.31.supplement_s61. J Nutr Sci Vitaminol (Tokyo). 1985. PMID: 3915757 Review.
Cited by
-
Vitamin D intake in mid-pregnancy and child allergic disease - a prospective study in 44,825 Danish mother-child pairs.BMC Pregnancy Childbirth. 2013 Oct 31;13:199. doi: 10.1186/1471-2393-13-199. BMC Pregnancy Childbirth. 2013. PMID: 24176134 Free PMC article.
-
Calciotropic hormones in elderly people with and without hip fracture.Osteoporos Int. 1995 Mar;5(2):103-7. doi: 10.1007/BF01623311. Osteoporos Int. 1995. PMID: 7599446
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical